Leptin Modulates the Response of Brown Adipose Tissue to Negative Energy Balance: Implication of the GH/IGF-I Axis

Int J Mol Sci. 2021 Mar 11;22(6):2827. doi: 10.3390/ijms22062827.

Abstract

The growth hormone (GH)/insulin-like growth factor I (IGF-I) axis is involved in metabolic control. Malnutrition reduces IGF-I and modifies the thermogenic capacity of brown adipose tissue (BAT). Leptin has effects on the GH/IGF-I axis and the function of BAT, but its interaction with IGF-I and the mechanisms involved in the regulation of thermogenesis remains unknown. We studied the GH/IGF-I axis and activation of IGF-I-related signaling and metabolism related to BAT thermogenesis in chronic central leptin infused (L), pair-fed (PF), and control rats. Hypothalamic somatostatin mRNA levels were increased in PF and decreased in L, while pituitary GH mRNA was reduced in PF. Serum GH and IGF-I concentrations were decreased only in PF. In BAT, the association between suppressor of cytokine signaling 3 and the IGF-I receptor was reduced, and phosphorylation of the IGF-I receptor increased in the L group. Phosphorylation of Akt and cyclic AMP response element binding protein and glucose transporter 4 mRNA levels were increased in L and mRNA levels of uncoupling protein-1 (UCP-1) and enzymes involved in lipid anabolism reduced in PF. These results suggest that modifications in UCP-1 in BAT and changes in the GH/IGF-I axis induced by negative energy balance are dependent upon leptin levels.

Keywords: GH axis; IGF-I signaling; UCP-1; brown adipose tissue; leptin; lipid metabolism.

MeSH terms

  • Adipose Tissue, Brown / drug effects*
  • Adipose Tissue, Brown / metabolism
  • Animals
  • Cyclic AMP Response Element-Binding Protein / genetics
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Energy Metabolism / drug effects*
  • Energy Metabolism / genetics
  • Glucose Transporter Type 4 / genetics
  • Glucose Transporter Type 4 / metabolism
  • Growth Hormone / genetics*
  • Growth Hormone / metabolism
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Injections, Intraventricular
  • Insulin-Like Growth Factor I / genetics*
  • Insulin-Like Growth Factor I / metabolism
  • Leptin / pharmacology*
  • Male
  • Phosphorylation / drug effects
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / metabolism
  • Somatostatin / genetics
  • Somatostatin / metabolism
  • Suppressor of Cytokine Signaling 3 Protein / genetics
  • Suppressor of Cytokine Signaling 3 Protein / metabolism
  • Thermogenesis / drug effects*
  • Thermogenesis / genetics
  • Uncoupling Protein 1 / genetics
  • Uncoupling Protein 1 / metabolism

Substances

  • Creb1 protein, rat
  • Cyclic AMP Response Element-Binding Protein
  • Glucose Transporter Type 4
  • Leptin
  • RNA, Messenger
  • Slc2a4 protein, rat
  • Socs3 protein, rat
  • Suppressor of Cytokine Signaling 3 Protein
  • Ucp1 protein, rat
  • Uncoupling Protein 1
  • Somatostatin
  • Insulin-Like Growth Factor I
  • Growth Hormone
  • Receptor, IGF Type 1
  • Proto-Oncogene Proteins c-akt